Tag Archives: Biotechnology

Hansa Biopharma Year-end record January-December 2022 

Complete 2022 earnings of SEK 155m Cash money path expanded right into 2025 Market Gain access to gotten in 4 of the 5 biggest European markets Reported favorable Stage 2 top-line information in AMR Choice made to launch professional research study with imlifidase as a pre-treatment to Sarepta’s SRP-9001 genetics treatment in 2023 LUND, Sweden, Feb. 2, 2023/… Read More »

Viatris Studies Robust Third Quarter 2022 Outcomes

Reaffirms 2022 Steering Ranges [1] Throughout Whole Revenues, Adjusted EBITDA and Free Money Stream; Pushed by Strong Working Momentum Regardless of International Change Headwinds and Absorbing Inflation Impression to Date Studies Whole Revenues of $4.08 billion; U.S. GAAP Internet Earnings of $354 million; Adjusted EBITDA of $1.50 billion; U.S. GAAP Internet Money Offered by Working Actions of $869… Read More »